Close Menu

NEW YORK ─ Seattle-based startup Tasso said on Wednesday that it has closed an oversubscribed $17 million Series A financing round and plans to use the proceeds to scale manufacturing and operations to meet the demand for its push-button blood collection devices.

Tasso OnDemand devices enable people to collect blood without training from the comfort and privacy of the home and mail samples to a CLIA-certified, high-complexity clinical laboratory for testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.